MedTech Innovator Welcomes Dr. Jeffrey Shuren as Advisor

LOS ANGELES--(BUSINESS WIRE)--Jun 18, 2026--

MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies, today announced that Dr. Jeffrey Shuren, former Director of the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), has joined the organization as an Advisor.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618646538/en/

Dr. Shuren brings more than two decades of leadership at the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services. Under his leadership at the FDA, CDRH advanced regulatory modernization efforts, strengthened patient protections, created innovation pathways, established new frameworks for digital health/artificial intelligence, advanced the use of real world evidence, and improved patient access to safe and effective medical technologies.

As an MTI Advisor, Dr. Shuren will provide strategic guidance to the organization, its accelerator, portfolio companies, and ecosystem on regulatory strategy, policy trends, and global market access, helping early- and mid-stage startups navigate increasingly complex regulatory environments.

“Jeff’s leadership at FDA transformed how medical technologies are evaluated and brought to market,” said Paul Grand, Founder & CEO of MedTech Innovator. “His experience accelerating innovation while maintaining rigorous patient safety standards will be invaluable to our portfolio companies to help avoid costly delays and increase the chance of success as they advance innovative solutions to benefit patients.”

During his tenure at FDA, Dr. Shuren led initiatives that included the Breakthrough Devices Program, the Patient Engagement Program, the Digital Health Center for Excellence, the Total Product Life Cycle Advisory Program (TAP), and Home as a Healthcare Hub. His work helped modernize regulatory science while supporting rapid innovation across medtech sectors including AI, diagnostics, wearables, and other life-saving therapeutic devices.

“MedTech Innovator plays a critical role in supporting the next generation of medical technology leaders,” said Dr. Shuren. “I’m excited to contribute to an organization that helps entrepreneurs translate transformative ideas into solutions that improve the health and quality of life of people globally.”

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing over 20,000+ applicants and fostering the growth of 838 graduates. Alumni have collectively raised $12 billion in follow-on funding, achieved 63 acquisitions, and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow MTI on LinkedIn, and subscribe to its monthly newsletter.

Jeffrey Shuren, MedTech Innovator Advisor

WASHINGTON (AP) — The Supreme Court sided Thursday with a Texas marijuana user who wants to legally own a gun, the latest in a line of firearm cases from a court that has expanded gun rights.

The justices sided with Ali Danial Hemani, who argued that a law barring guns from anyone who uses drugs illegally violates the Second Amendment. Hemani wasn’t charged with any other crimes or accused of using the weapon under the influence.

The decision is a loss for President Donald Trump’s Republican administration, which had defended the 1968 law despite arguing against other gun restrictions. The measure was also used in a case against Hunter Biden, who was convicted in Wilmington, Delaware, of buying a gun while addicted to cocaine in 2018. He was later pardoned by his father, then-President Joe Biden, a Democrat.

The opinion is the latest in a series of firearm cases to reach the Supreme Court since a landmark ruling expanding gun rights in 2022 led to a wave of challenges around the country.

Since then, the high court has upheld a law aimed at protecting victims of domestic violence and strict regulations on ghost gun kits but has struck down a ban on bump stocks, an accessory that enables rapid fire. The justices considered two firearm cases this term alone.

The legality and use of cannabis, meanwhile, has also shifted significantly in recent years. More than half of U.S. states have now legalized it broadly, and it’s gained widespread use for health purposes.

Recreational use remains illegal on a federal level, however, even after the Trump administration reclassified medical marijuana as a less-dangerous drug in April.

It’s rare to see standalone criminal charges filed against people accused of owning guns and using drugs. The charge is more often filed against people also accused of other crimes.

The case made for some unusual political alliances. The American Civil Liberties Union and the National Rifle Association both supported Hemani’s case, as did cannabis legalization groups like NORML. On the other side were gun safety groups like Everytown that usually oppose the Trump administration on Second Amendment issues.

Follow the AP’s coverage of the U.S. Supreme Court at https://apnews.com/hub/us-supreme-court.

FILE - The U.S. Supreme Court is seen, June 11, 2026, in Washington. (AP Photo/Mariam Zuhaib, File)